| AMD | Age-related macular degeneration |
| Anti-VEGF | Drugs that inhibit vascular endothelial growth factor |
| BRVO | Branch retinal vein occlusion |
| CRVO | Central retinal vein occlusion |
| DARPins | Designed ankyrin repeat proteins |
| DME | diabetic macular edema |
| DR | Diabetic retinopathy |
| EG-VEGF | Endocrine gland-derived vascular endothelial growth factor |
| IOI | Intraocular inflammation |
| IOP | Intraocular pressure |
| ME | Macular edema |
| NP-1 | Neuropilin-1 |
| NP-2 | Neurophilin-2 |
| NPDR | Non-proliferative diabetic retinopathy |
| PCV | Polypoidal choroidal vasculopathy |
| PDR | Proliferative diabetic retinopathy |
| PDT | Photodynamic therapy |
| PlGF | Placental growth factor |
| POHS | Presumed ocular histoplasmosis syndrome |
| PRP | Panretinal laser photocoagulation |
| RPE | Retinal pigment epithelium |
| RVO | Retinal vein occlusion |
| VEGF | Vascular endothelial growth factor |
| VEGFR | Vascular endothelial growth factor receptor |